Cost-effectiveness of the regimen proposed by the International Consortium on Acute Promyelocytic Leukemia for the treatment of newly diagnosed patients with Acute Promyelocytic Leukemia.

Sergio Rodríguez-Rodríguez,Lorena Guerrero-Torres,María José Díaz-Huízar,Alan Pomerantz,María Del Pilar Ortíz-Vilchis,Roberta Demichelis-Gómez

Blood（2021）

引用 1|浏览4

暂无评分

摘要

Taking into account the similar response rates, lower cost and easy access to the modified IC-APL regimen, we consider it a cost-effective and cost-utility protocol, deeming it the treatment of choice for our population.

查看译文

关键词

Acute promyelocytic leukemia,All-trans retinoic acid,Cost-effectiveness,Cost-utility,IC-APL

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要